Tag Archives: Supreme Court

AMP Petitions for Cert. and A Look Back

The Association for Molecular Pathology (AMP) has petitioned the Supreme Court to review the Fed. Cir.’s opinion of July 29th, that isolated BRCA DNA sequences are patentable subject matter. Its brief (a copy available at the end of this post) … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , , , , , , , | 1 Comment

Oral Argument in Mayo v. Prometheus – Why Mayo Will Lose

On December 7th at 10:05 a.m., the Supreme Court heard oral arguments (transcript at end of this post) in the “Prometheus case,” presented by Stephen M. Shapiro of Meyer Brown (Mayo) and Richard P. Bess of Latham & Watkins. Solicitor … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , | 1 Comment

HUMAN GENOME SCIENCES v. ELI LILLY – Increased European Harmony?

By Paul Cole, European Patent Attorney, Lucas & Co – Warlingham, UK Judgement – Human Genome Sciences Inc (Appellant) v Eli Lilly and Company (Respondent) The above proceedings relate to European Patent (UK) 0,939,804 concerning a new  human  protein called Neutrokine-α. … Continue reading

Posted in EP and UK Practice | Tagged , , , , , , | 1 Comment

Prometheus’s Brief – Don’t Confuse Us With “LabCorp”

It took me a while to get around to reading Prometheus’s brief to the Supreme Court in Mayo v. Prometheus Labs., No. 10-1150 (S. Ct. Oct. 31, 2011), because I was pretty sure how it would read and, in fact, … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , | Leave a comment